by mm-red | Jul 28, 2020
Background: Omalizumab is an effective and well-tolerated treatment for chronicspontaneous urticaria (CSU). Markers and predictors of response are largelyunknown, but needed to optimize omalizumab treatment. Omalizumab targets IgE,and IgE levels may be linked to the...
Recent Comments